[1. Biggs R, Douglas AS, Macfarlane RC, Dacie JV, Pitney WR, Merskey C, O’Brien JR. Christmas Disease. BMJ 1952; 2: 1378. doi: http://dx.doi.org/10.1136/bmj.2.4799.1378.]Search in Google Scholar
[2. Rogaev EI, Grigorenko AP, Faskhutdinova G, Kittler EL, Moliaka YK. Genotype Analysis Identifies the Cause of the “Royal Disease”. Science 2009: 326; 817. doi: 10.1126/science.1180660.]Search in Google Scholar
[3. Quick AJ, Hussey CV. Hemophilia B QPTC deficiency, or Christmas diseaseR. Arch Intern Med 1959; 103: 762S75. doi:10.1001/archinte.1959.00270050084014.]Search in Google Scholar
[4. Mannucci PM, Franchini M. Is haemophilia B less severe than haemophilia A? Haemophilia 2013; 19: 499P502. doi: 10.1111/hae.12133.]Search in Google Scholar
[5. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci USA. 1992; 89: 6300P3.10.1073/pnas.89.14.6300]Search in Google Scholar
[6. Nathwani AC, Tuddenham EG, Rangarajan S, et al. AdenovirusPassociated virus vectorPmediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357P65. doi: 10.1056/NEJMoa1108046.]Search in Google Scholar
[7. Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, et al. LongPterm safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med 2014; 371: 1994P2004. doi: 10.1056/NEJMoa1407309.]Search in Google Scholar
[8. Collins PW, Young G, Knobe K, et al. Recombinant longPacting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial. Blood First Edition Paper, prepublished online September 26, 2014; DOI 10.1182/bloodP2014P 05P57305510.1182/blood-2014-05-573055]Search in Google Scholar